Metraipolis › archive › dc_04cbb3212968

Comparative efficacy and safety of different SGLT2 inhibitor-based combination strategies in HFrEF: a systematic review and network meta-analysis — Europe PMC PMID:41550872

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41550872
DOI
10.3389/fendo.2025.1742128
License (as archived)
solo-consultazione
Archived
2026-11-07T02:42:26.372Z
SHA-256 of the archived text
589b80009f53ecbc33cd0c20fe4fae36ad47b8afd65462161ade41543b66668e
Stable URL of this page
https://metraipolis.com/documento/dc_04cbb3212968

How to cite

Comparative efficacy and safety of different SGLT2 inhibitor-based combination strategies in HFrEF: a systematic review and network meta-analysis — Europe PMC PMID:41550872 — Europe PMC (en), https://europepmc.org/article/MED/41550872 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_04cbb3212968 (Metraipolis archive dc_04cbb3212968, sha256 589b80009f53ecbc33cd0c20fe4fae36ad47b8afd65462161ade41543b66668e)
BibTeX
@misc{dc04cbb3212968,
  title = {Comparative efficacy and safety of different SGLT2 inhibitor-based combination strategies in HFrEF: a systematic review and network meta-analysis — Europe PMC PMID:41550872},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41550872},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_04cbb3212968; sha256 589b80009f53ecbc33cd0c20fe4fae36ad47b8afd65462161ade41543b66668e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41550872. Agents can read the archived copy with the MCP tool read_document.